In Vitro Activities of Quinupristin-Dalfopristin and the Streptogramin RPR 106972 against Mycoplasma pneumoniae
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (3) , 698-699
- https://doi.org/10.1128/aac.42.3.698
Abstract
The in vitro activities of quinupristin-dalfopristin and streptogramin RPR 106972 were determined with 44 strains of Mycoplasma pneumoniae and compared to those of macrolides, minocycline, and quinolones. All isolates tested were highly susceptible to macrolides and to quinupristin-dalfopristin (MIC at which 90% of the isolates are inhibited [MIC 90 ], 0.0625 μg/ml), followed by RPR 106972 (MIC 90 , 0.5 μg/ml), quinolones, and minocycline.Keywords
This publication has 14 references indexed in Scilit:
- Quinupristin-DalfopristinDrugs, 1996
- Mechanism of Action of Streptogramins and MacrolidesDrugs, 1996
- StreptograminsDrugs, 1996
- Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 1995
- In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogensAntimicrobial Agents and Chemotherapy, 1995
- In vitro and in vivo activities of macrolides against Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 1994
- In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 1994
- In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391Antimicrobial Agents and Chemotherapy, 1991
- In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1988
- Antimycoplasmal activity of ofloxacin (DL-8280)Antimicrobial Agents and Chemotherapy, 1983